Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
HeartSciences Inc. - Warrant
(NQ:
HSCSW
)
0.0385
-0.0120 (-23.76%)
Streaming Delayed Price
Updated: 1:28 PM EDT, Jul 28, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
19,245
Open
0.0501
Bid (Size)
0.0390 (100)
Ask (Size)
0.0657 (500)
Prev. Close
0.0505
Today's Range
0.0385 - 0.0502
52wk Range
0.0350 - 0.1787
Shares Outstanding
10,362,284
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
HeartSciences Files Its Fiscal 2026 Annual Report on Form 10-K
July 23, 2026
Company believes proposed Fortitude merger represents a significant opportunity for the Company’s shareholders; preliminary proxy statement in connection with the Proposed Transaction expected to be...
From
HeartSciences Inc.
Via
GlobeNewswire
European Patent Granted for ECG-Based Assessment of Diastolic Function, Expands HeartSciences’ Patent Portfolio to More Than 45 Granted Patents
June 11, 2026
Patent covers machine-learning models that use ECG data to estimate echocardiogram parameters indicative of diastolic function
From
HeartSciences Inc.
Via
GlobeNewswire
Performance
YTD
-50.3%
-50.3%
1 Month
-23.3%
-23.3%
3 Month
-41.6%
-41.6%
6 Month
-63.8%
-63.8%
1 Year
-76.7%
-76.7%
More News
Read More
HeartSciences Launches MyoVista Insights™ Version 1.3 with AI-ECG Algorithm Marketplace and First FDA-Cleared Algorithm
June 02, 2026
From
HeartSciences Inc.
Via
GlobeNewswire
HeartSciences Signs Commercial Agreement with North Shore Health, the First Hospital Deployment from the Cibolo Health Network
May 19, 2026
From
HeartSciences Inc.
Via
GlobeNewswire
HeartSciences Signs First SaaS Revenues Agreement following full launch of MyoVista Insights™
May 05, 2026
From
HeartSciences Inc.
Via
GlobeNewswire
HeartSciences Reminds Its Shareholders to Submit Their Vote at the Upcoming April 30, 2026, Annual Shareholders Meeting
April 14, 2026
From
HeartSciences Inc.
Via
GlobeNewswire
HeartSciences’ MyoVista Insights™ Receives Epic Toolbox Designation for ECG Management System Category
March 25, 2026
From
HeartSciences Inc.
Via
GlobeNewswire
HeartSciences to Present at Investor Summit Group Virtual Conference and Host Virtual One on One Investor Meetings
March 24, 2026
From
HeartSciences Inc.
Via
GlobeNewswire
HeartSciences Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update
March 16, 2026
From
HeartSciences Inc.
Via
GlobeNewswire
University of West England Adopts HeartSciences’ MyoVista Insights™ Platform and MyoVista® wavECG™ Device to Establish ECG Education and Technology Reference Center
February 05, 2026
From
HeartSciences Inc.
Via
GlobeNewswire
Cibolo Health Designates HeartSciences’ MyoVista Insights™ as Endorsed ECG Management Platform for Network of 123 Independent Hospitals
January 29, 2026
From
HeartSciences Inc.
Via
GlobeNewswire
HeartSciences Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update
December 15, 2025
From
HeartSciences Inc.
Via
GlobeNewswire
HeartSciences Announces FDA 510(k) Submission for MyoVista® wavECG™ Device
December 15, 2025
From
HeartSciences Inc.
Via
GlobeNewswire
HeartSciences Announces Major Upgrade to User Features of MyoVista Insights Platform with Commercial Launch Version 1.1
December 11, 2025
From
HeartSciences Inc.
Via
GlobeNewswire
HeartSciences Provides Business Update and Reports First Quarter of Fiscal 2026 Financial Results
September 11, 2025
From
HeartSciences Inc.
Via
GlobeNewswire
HeartSciences Announces Conference Participation and Investor Webinar
August 15, 2025
From
HeartSciences Inc.
Via
GlobeNewswire
HeartSciences Provides Business Update and Reports Fiscal 2025 Financial Results
July 24, 2025
From
HeartSciences Inc.
Via
GlobeNewswire
HeartSciences Receives FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm for Detecting Aortic Stenosis
June 04, 2025
From
HeartSciences Inc.
Via
GlobeNewswire
Foundational US Patent Granted for ECG Assessment of Heart Function, Further Expands HeartSciences’ Patent Portfolio and IP Value
June 03, 2025
From
HeartSciences Inc.
Via
GlobeNewswire
HeartSciences Signs First MyoVista Insights™ Platform Customer, Marking Major Commercial Milestone
May 29, 2025
From
HeartSciences Inc.
Via
GlobeNewswire
HeartSciences’ CEO Andrew Simpson to Present at Emerging Growth Conference 82 on Wednesday, May 21, 2025
May 20, 2025
From
Heart Test Laboratories, Inc.
Via
GlobeNewswire
HeartSciences to Host Investor Webinar and Q&A on Wednesday May 14, 2025 - Featuring CEO Andrew Simpson
May 08, 2025
From
Heart Test Laboratories, Inc.
Via
GlobeNewswire
HeartSciences Adds Prominent Key Advisors to its Scientific Advisory Board
May 07, 2025
From
Heart Test Laboratories, Inc.
Via
GlobeNewswire
HeartSciences Announces Launch of MyoVista Insights™ Platform and Related Early Adopter Program
May 01, 2025
From
Heart Test Laboratories, Inc.
Via
GlobeNewswire
HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2025 Financial Results
March 13, 2025
From
Heart Test Laboratories, Inc.
Via
GlobeNewswire
Frequently Asked Questions
Is HeartSciences Inc. - Warrant publicly traded?
Yes, HeartSciences Inc. - Warrant is publicly traded.
What exchange does HeartSciences Inc. - Warrant trade on?
HeartSciences Inc. - Warrant trades on the Nasdaq Stock Market
What is the ticker symbol for HeartSciences Inc. - Warrant?
The ticker symbol for HeartSciences Inc. - Warrant is HSCSW on the Nasdaq Stock Market
What is the current price of HeartSciences Inc. - Warrant?
The current price of HeartSciences Inc. - Warrant is 0.0385
When was HeartSciences Inc. - Warrant last traded?
The last trade of HeartSciences Inc. - Warrant was at 07/28/26 01:28 PM ET
What is the market capitalization of HeartSciences Inc. - Warrant?
The market capitalization of HeartSciences Inc. - Warrant is 398.95K
How many shares of HeartSciences Inc. - Warrant are outstanding?
HeartSciences Inc. - Warrant has 399K shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
